Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit
Biomind Labs (OTCQB:BMNDF) has begun administering its proprietary second-generation psychedelic, BMND01, in a Phase 1/2a clinical trial for treatment-resistant depression (TRD).
Three weeks after announcing the results of its preclinical trials for CYB003, Cybin (NYSE:CYBN) made public a partnership with Clinilabs Drug Development Corporation to take the proprietary drug to it
Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”
Irwin Natural’s (OTCQB: IWINF) Irwin Naturals Cannabis, Inc., entered into a licensing agreement with California-based The Hive Laboratory, LLC, which will produce and distribute some of Irwin Naturals’ formulas, such as Power to Sleep, which is augmented with THC.
Leonard Tannenbaum, founder, chairman and CEO of AFC Gamma Inc (NASDAQ: AFCG), does not hold much hope the SAFE Banking Act will pass into law this year
In an interview with Complex to promote his clothing brand MSFTSrep, Jaden Smith talked about his experience with psychedelics and said he is looking to be a “psychedelics world leader.”
With the goal of becoming the world’s largest chain of psychedelic mental health clinics, Irwin Naturals Inc. (OTCQB: IWINF) announced the acquisition of five ketamine treatment clinics in Florida and a partnership contract with two clinics in Mexico.